Ectopic pregnancy is one of the major causes of morbidity and mortality, accounting for 1 to
2% of all pregnancies. With the introduction of recent developments in diagnostic tools, the …

Objective To determine whether the success of treatment with single-dose methotrexate (SD
MTX) for ectopic pregnancy can be predicted using the rate of change in serum β-human …

Because early prediction of clinical outcome (one or more injections or surgery) of
methotrexate treatment of ectopic pregnancy could ease the intensity of follow-up and …

OBJECTIVE: The purpose of this study was to evaluate beta–human chorionic gonadotropin
(β-hCG) levels between days 0 and 4 as a predictor of methotrexate therapy success for …

Research question Several studies have tried to identify early markers of treatment outcome
after methotrexate (MTX) treatment for ectopic pregnancy, including pretreatment and day 4 …

Purpose The purpose of this study was to evaluate the initial and day 4 beta-human
chorionic gonadotropin (β-hCG) levels as a predictor of methotrexate (MTX) therapy success …

OBJECTIVE: To assign cutoff values for human chorionic gonadotropin (β-hCG) in
pretreatment and after one methotrexate (MTX) cycle and determine its correspondence to …

Objective To evaluate serum human chorionic gonadotropin (HCG) levels 0–4 days after
single‐dose methotrexate administration for tubal ectopic pregnancy. Methods The present …

Objective To evaluate β‐human chorionic gonadotropin (β‐HCG) level and its 24‐hour
increment as predictors of successful methotrexate treatment for ectopic pregnancy …

Background: Ectopic pregnancy treatment with a single dose of methotrexate, causes
patients to stay in hospital for a long time, increases the cost of treatment, decreases the …